The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1134-1138

  Ellis, William J ^a   Vessella, Robert L ^a   Corey, Eva ^a   Arfman, Edward W ^a   Oswin, Matthew M ^a   Melchior, Sebastian ^a   Lange, Paul H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Neoplasm metastasis; Polymerase chain reaction; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031897164     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63530-4     Document Type: Article

References (25)

1. Ohori, M., Wheeler, T. M., Dunn, J. K., Stamey, T. A. and Scardino, P. T.: Pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J. Urol., 152: 1714, 1994.
2. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage, and Gleason score to predict pathologic stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
3. Bostwick, D. G., Qian, J., Bergstralh, E., Dundore, P., Dugan, J., Myers, R. P. and Oesterling, J. E.: Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J. Urol., 155: 1361, 1996.
4. Ellis, W. J. and Brawer, M. K.: The role of tumor markers in the diagnosis and treatment of prostate cancer. In: Prostate Diseases. Edited by H. Lepor and R. K. Lawson. Philadelphia: W. B. Saunders Co., chapt. 22, pp. 276-291, 1993.
5. Vessella, R. L., Riley, D. E., Blouke, K. A., Arfman, E. W. and Lange, P. H.: A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction. J. Urol., part 2, 147: 441A, abstract 914, 1992.
6. Olsson, C. A., DE Vries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K., Cao, Y., Buttyan, R. E. and Katz, A. E.: Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155: 1557, 1996.
7. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F. and Rosai, J.: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195, 1995.
8. Jaakkola, S., Vornanen, T., Leinonen, J., Rannikko, S. and Stenman, U. H.: Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin. Chem., 41: 182, 1995.
9. Sokoloff, M. H., Tso, C.-L., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., deKernion, J. and Belldegrun, A.: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156: 1560, 1996.
10. Ignatoff, J. M., Oefelin, M. G., Herz, B., Watkin, W. and Kaul, K. L.: Prostate specific antigen (PSA) reverse transcriptase-polymerase chain reaction (RT-PCR) assay in preoperative staging of prostate cancer. J. Urol., part 2, 155:, 417A, abstract 427, 1996.
11. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G. and DeWolf, W.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
12. Corey, E., Arfman, E. W., Liu, A. Y. and Vessella, R. L.: Improved protocol for reverse-transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin. Chem., 43: 443, 1997.
13. Ellis, W. J., Vessella, R. L., Noteboom, J. L., Lange, P. H., Wolfert, R. L. and Rittenhouse, H. G.: Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Urology, 50: 573, 1997.
14. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, chapt. 9, pp. 171-198, 1977.
15. American Joint Committee on Cancer: Genitourinary cancers: prostate. In: Manual for Staging of Cancer, 4th ed. Edited by O. H. Beahrs, D. R. Henson, R. V. P. Hutter and B. J. Kennedy. Philadelphia: J. B. Lippincott Co., pp. 181-186, 1992.
16. Smith, M. R., Biggar, S. and Hussain, M.: Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res., 55: 2640, 1995.
17. Ellis, W. J. and Brawer, M. K.: Repeat prostate needle biopsy: who needs it? J. Urol., 153: 1496, 1995.
18. Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Layton, T. J., Oswin, M. M., Lange, P. H. and Vessella, R. L.: Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin. Cancer Res., 3: 249, 1997.
19. Loric, S., Dumas, F., Eschwege, P., Blanchet, P., Benoit, G., Jardin, A. and Lacour, B.: Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem., 41: 1698, 1995.
20. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T. and Wise, G. J.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
21. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994.
22. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.
23. Eschwege, P., Dumas, F., Blanchet, P., Le Maire, V., Benoit, G., Jardin, A., Lacour, B. and Loric, S.: Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet, 346: 1528, 1995.
24. Moreno, J. G., Long, J. P., O'Hara, M., Veltri, R. W., Alexander, A., Shupp-Byrne, D., Gomella, L. G.: Surgical prostatic instrumentation causes showering of prostate cells into the circulation as determined by RT-PCR of PSA. J. Urol., part 2, 155: 553A, abstract 970, 1996.
25. Cama, C. L., Olsson, C. A., Buttyan, R., Wise, G. J., DeVries, G. and Katz, A. E.: Molecular staging of prostate cancer III -effects of digital rectal examination, cystoscopy, and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J. Urol., part 2, 155: 553A, abstract 971, 1996.